References
- 1. Association for Motor Disabilities an multiple sclerosis, Bulgarian Association of Neurologists. [National consensus for diagnosing and treatment of multiple sclerosis]. Milonov I, editor, 2021. Bulgarian.
- 2. Drenska K. [Multiple Sclerosis and Comorbidity – Impact on the Quality of Life] [Dissertation]. Varna: Medical University-Varna; 2016. Bulgarian.
- 3. Trenova A. [Multiple Sclerosis – Genetic, Immunological and Clinico-neuropsychological Correlations] [Dissertation]. Plovdiv: Medical University-Plovdiv; 2018. Bulgarian.
- 4. GBD 2016 Motor Neuron Disease Collaborators. Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(12):1083-97.
- 5. Zlatareva E, Milanov I, Ivanova SH, Georgiev DP. Tumor-like lesions in a patient diagnosed with multiple sclerosis as non-onset manifestation of the disease. Mov disor. 2020;17(1):47-52.
- 6. Azis T, Roy H. Indications and approaches for functional neurosurgery in multiple sclerosis, including the role for lesion surgery and deep brain stimulation. MRA. 2020;8(6):2-14.10.18103/mra.v8i6.2147
- 7. Mladenoski M, Vasilev N, Ovcharov M, Valkov I. Basic neuronavigation options for cortical and subcortical brain lesions surgery. J Biomed Clin Res. 2018;11(2):141-9.10.2478/jbcr-2018-0020
- 8. Al Ammar W, Albeesh F, Ibrahim L, Algindan Y, Yamani L, Khattab R. Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review. Nutr Neurosci. 2021;24(7):569-79.10.1080/1028415X.2019.165956031462182
- 9. Avallone R, Vitale G, Bertolotti M. Omega-3 fatty acids and neurodegenerative diseases: New evidence in clinical trials. Int J Mol Sci. 2019;20(17), 4256.10.3390/ijms20174256
- 10. Black LJ, Baker K, Ponsonby AL, van der Mei I, Lucas RM, Pereira G. A Higher Mediterranean diet score, including unprocessed red meat, is associated with reduced risk of Central Nervous System demyelination in a case-control Study of Australian adults. J Nutr. 2019;149(8):1385-92.10.1093/jn/nxz08931131415
- 11. Bromley L, Horvath PJ, Bennett SE, Weinstock-Guttman B, Ray AD. Impact of nutritional intake on function in people with mild-to-moderate multiple sclerosis. Int J MS Care. 2019;21(1)1-9.10.7224/1537-2073.2017-039639082030833865
- 12. MS-UK [Internet]. Diet and supplements. Choices booklet. 2019. Available from: https://ms-uk.org/choices-diet-and-supplements-content/
- 13. Evans E, Levasseur V, Cross AH, Piccio L. An overview of the current state of evidence for the role of specific diets in multiple sclerosis. Mult Scler Relat Disord. 2019;36:101393.10.1016/j.msard.2019.10139331574403
- 14. Fitzgerald KC, Sand IK, Senders A, Spain R, Giesser B, et al. Conducting dietary intervention trials in people with multiple sclerosis: Lessons learned and a path forward. Mult Scler Relat Disord. 2019;37:101478.10.1016/j.msard.2019.10147831704546
- 15. Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, et al. International society for nutritional psychiatry research practice guidelines for omega-3 fatty acids in the treatment of Major Depressive Disorder. Psychother Psychosom. 2019;88(5):263-73.10.1159/00050265231480057
- 16. Ruiz1 F, Vigne1 S, Pot C. Resolution of inflammation during multiple sclerosis. Semin Immunopathol. 2019;41(6):711-726.10.1007/s00281-019-00765-0688124931732775
- 17. Siegert E, Paul F, Rothe M, Weylandt KH. The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice. BMC Neurosci. 2017;18(1):19.10.1186/s12868-016-0312-5525986328114887
- 18. Yadav V, Marracci G, Kim E, Spain R, Cameron M, Overs S, et al. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial. Mult Scler Relat Disord. 2016;9:80-90.10.1016/j.msard.2016.07.00127645350
- 19. Parikh R, Bates JH, Poynter ME, Suratt BT, Parsons PE, Kein SL, et al. Pharmacokinetics of omega-3 fatty acids in patients with severe sepsis compared with healthy volunteers: A prospective cohort study. Clin Nutr. 2020;39(3):958-65.10.1016/j.clnu.2019.03.040678538331005335
- 20. Kouchaki E, Afarini M, Abolhassani J, Mirhosseini N, Bahmani F, Masoud SL, et al. High-dose ω-3 fatty acid plus vitamin D3 supplementation affects clinical symptoms and metabolic status of patients with multiple sclerosis: A randomized controlled clinical trial. J Nutr. 2018;148(8):1380-6.10.1093/jn/nxy11629982544
- 21. Labuschagne IL, Blaauw R. An anti-inflammatory approach to the dietary management of multiple sclerosis: a condensed review. South Afr J Clin Nutr. 2018;31(3):67-73.10.1080/16070658.2018.1465652
- 22. Langer-Gould A, Black LJ, Waubant E, Smith JB, Wu J. Seafood fatty acid biosynthesis genes, and multiple sclerosis susceptibility. Mult Scler J. 2020;26(12):1476-85.10.1177/1352458519872652757320033063621
- 23. Li X, Bi X, Wang S, Zhang Z, Li F, Zhao AZ. Therapeutic potential of ω-3 polyunsaturated fatty acids in human autoimmune diseases. Front Immunol. 2019;10:2241.10.3389/fimmu.2019.02241677688131611873
- 24. Capone F, Collorone S, Cortese R, Di Lazzaro V, Moccia M. Fatigue in multiple sclerosis: The role of thalamus. Mult Scler. 2020;26(1):6-16.10.1177/135245851985124731138052
- 25. Cipollini V, Anrather J, Orzi F, Iadecola C. Th17 and cognitive impairment: possible mechanisms of action. Front Neuroanat. 2019;13:95.10.3389/fnana.2019.00095687748131803028
- 26. De Souza Moreira BB, de Almeida Franzoi AE, Gonзalves MVM, do Nascimento OJM, Becker J, Peron JPS. Lymphocytes T Helper 17 in multiple sclerosis: regulation by intestinal microbiota. J Neurol Exp Neurosci. 2019;5(1): 40-7.10.17756/jnen.2019-051
- 27. Drenska K, Drenski T, Kaprelyan A. Feeling of happiness in patients with multiple sclerosis and comorbidity. J of IMA. 2019;25(1):2390-5.10.5272/jimab.2019251.2390
- 28. Gutierrez S, Svahn SL, Johansson ME. Effects of Omega-3 fatty acids on immune cells. Int J Mol Sci. 2019;20(20), 5028.10.3390/ijms20205028
- 29. Mousavi Nasl-Khameneh A, Mirshafiey A, Naser Moghadasi A, Chahardoli R, Mahmoudi M, Parastouei K, et al. Combination treatment of docosahexaenoic acid (DHA) and all-transretinoic acid (ATRA) inhibit IL-17 and RORγt gene expression in PBMCs of patients with relapsing-remitting multiple sclerosis. Neurol Res. 2018;40(1):11-17.10.1080/01616412.2017.138280029155646
- 30. Maxwell K, Wahls T, Browne RW, Rubenstein L, Bisht B, Chenard C, et al. Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot study. PLoS One. 2019;14(6):e0218075.10.1371/journal.pone.0218075658125631211794
- 31. Penesova A, Dean Z, Kollar B, Havranova A, Imrich R, Vlček M, et al. Nutritional intervention as an essential part of multiple sclerosis treatment? Physiol Res. 2018;67(4):521-33.10.33549/physiolres.93369429750884
- 32. Pommerich UM, Brincks J, Christensen ME. Is there an effect of dietary intake on MS-related fatigue? A systematic literature review. Mult Scler Relat Disord. 2018;25:282-91.10.1016/j.msard.2018.08.01730170268
- 33. Reimers A, Ljung H. The emerging role of omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders. Ther Adv Psychopharmacol. 2019;9:1-18.10.1177/2045125319858901659166431258889
- 34. Tryfonos C, Mantzorou M, Fotiou D, Vrizas M, Vadikolias K, Pavlidou E, et al. Dietary supplements on controlling multiple sclerosis symptoms and relapses: current clinical evidence and future perspectives. Medicines (Basel). 2019;6(3):95.10.3390/medicines6030095678961731547410
- 35. Drenska K, Drenski T, Kaprelyan A, Dimitrov I. [Fatigue in patients with multiple sclerosis with and without concomitant diseases]. Neurology and psychiatry. 2017;XLVIII(3):26-8. Bulgarian
- 36. Sepidarkish M, Akbari-Fakhrabadi M, Daneshzad E, Yavari M, Rezaeinejad M, Morvaridzadeh M, et al. Effect of omega-3 fatty acid plus vitamin E Co-Supplementation on oxidative stress parameters: A systematic review and meta-analysis. Clin Nutr. 2020;39(4):1019-25.10.1016/j.clnu.2019.05.00431128941
- 37. Shinto L, Marracci G, Mohr DC, Bumgarner L, Murchison C, Senders A, et al. Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study. PLoS One. 2016;11(1):e0147195.10.1371/journal.pone.0147195472331626799942
- 38. Shrestha P, Zhou XR, Pillai SV, Petrie J, de Feyter R, Singh S. Comparison of the substrate preferences of ω-3 fatty acid desaturases for long chain polyunsaturated fatty acids. Int J Mol Sci. 2019;20(12):3058.10.3390/ijms20123058662740831234541
- 39. Torkildsen O, Wergeland S, Bakke S, Beiske AG, Bjerve K, Hovdal H, et al. ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial. Arch Neurol. 2012;69(8):1044-51.10.1001/archneurol.2012.28322507886
- 40. Van AL, Hachem M, Lagarde M, Bernoud-Hubac N. Omega-3 Docosahexaenoic Acid is a mediator of fate-decision of adult neural stem cells. Int J Mol Sci. 2019;20(17),4240.10.3390/ijms20174240
- 41. Hass U, Herpich C, Norman K. Anti-inflammatory diets and fatigue. Nutrients. 2019;11(10):2315.10.3390/nu11102315683555631574939
- 42. Ishihara T, Yoshida M, Arita M. Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis. Int Immunol. 2019;31(9):559-67.10.1093/intimm/dxz00130772915
- 43. Katz-Sand I. The role of diet in multiple sclerosis: mechanistic connections and current evidence. Curr Nutr Rep. 2018;7(3):150-60.10.1007/s13668-018-0236-z613238230117071
- 44. Katz-Sanda I, Bennb E, Fabiana M, Fitzgeraldc K, Digga E, Deshpande R, et al. Randomized-controlled trial of a modified Mediterranean dietary program for multiple sclerosis: A pilot study. Mult Scler Relat Disord. 2019;36:101403.10.1016/j.msard.2019.10140331610401
- 45. Sayon-Orea C, Razquin C, Bullo M, Corella D1, Fito M, Romaguera D, et al. Effect of a nutritional and behavioral intervention on energy-reduced Mediterranean diet adherence among patients with metabolic syndrome: Interim analysis of the PREDIMED-Plus randomized clinical trial. JAMA. 2019;322(15):1486-99.10.1001/jama.2019.14630680227131613346
- 46. Weinstock-Guttman B, Baier M, Park Y, Feichter J, Lee-Kwen P, et al. Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids. 2005;73(5):397-404.10.1016/j.plefa.2005.05.02416099630
- 47. Miller ED, Dziedzic A, Saluk-Bijak J, Bijak M. A review of various antioxidant compounds and their potential utility as complementary therapy in multiple sclerosis. Nutrients. 2019;11(7):1528.10.3390/nu11071528668297231284389
- 48. Gardener H, Scarmeas N, Gu Y, Boden-Albala B, Elkind M, Sacco R, et al. Mediterranean diet and white matter hyperintensity volume in the Northern Manhattan Study. Arch Neurol. 2012;69(2):251-6.10.1001/archneurol.2011.548328155022332193
- 49. Mische LJ, Mowry E. The evidence for dietary interventions and nutritional supplements as treatment options in multiple sclerosis: a review. Curr Treat Options Neurol. 2018;20(4):8.10.1007/s11940-018-0494-529549521